Academy of Pharmacy and Pharmaceutical Sciences

18/01/2022

Master and PhD scholarships for international students

Australian Government Research Training Program 2022 are now accepting application for Masters & Ph.D. Main goal of Australian Government high-quality research.

14/10/2021

There is an exciting new PhD project available [Evaluation of medication use and management among patients with dementia in Australian general practice] at the School of Pharmacy and Pharmacology, University of Tasmania, Australia

The scholarship supporting this project provides:

– a living allowance stipend of $28,597 per annum (2021 rate, indexed annually) for 3.5 years;
– a relocation allowance of up to $2,000;
– a tuition fee scholarship for up to 4 years.

Selection Criteria:

– A degree with a substantial research project (e.g. Research Masters’ degree, Masters’ degree with treatise component, or Bachelor degree with first-class Honours)
– Excellent analysis and writing skills, demonstrated by publications in peer-reviewed journals
– Demonstrate some understanding of statistical methods and proficiency with any data analysis software
– Exceptional interpersonal communication skills and demonstrated ability to work in teams
– Capacity to work with a range of disciplines and having prior clinical knowledge
– Evidence of project management and organisation ability, including the ability to fulfil goals and deliver outcomes within a specified period

Your Expression of Interest should include:

– Your CV and copy of academic transcript(s)
– List of two or three potential academic referees and/or line managers
– Sample of written work, ideally appropriate for an academic audience (e.g. honours thesis, peer-reviewed journal article, essay written during coursework study or similar)

Applications close: 24 October 2021

We are currently seeking expressions of interest for a full-time PhD position within the School of Pharmacy and Pharmacology at University of Tasmania, subject to successfully obtaining a University Doctoral Scholarship. The successful candidate will be expected to commence as soon as possible, but....

25/09/2021

Positive results from COVID-19 Vaccine trials for 5 to 11 year olds

22/09/2021

PhD Scholarship in Exercise Oncology (For International Students)
Edith Cowan University - Exercise Medicine Research Institute, Perth, Australia

EMRI is calling for international applications to be considered for Research Scholarships which include a stipend of $30,000 AUD per annum (tax-free) to undertake a PhD in the Exercise Medicine Research Institute at Edith Cowan University. The scholarship also includes a full tuition sponsorship worth $29,750 (Australian resident) to $36,300 (international) per annum plus support for conference attendance and research expenses.

For more information

To learn more about this excellent opportunity, please contact Professor Daniel Galvão (galvao@ecu.edu.au) or Professor Robert Newton (r.newton@ecu.edu.au).
To explore their research and clinical work and get to know their team please go to their website exercisemedicine.org.au

22/09/2021

The world's richest countries could have 1.2bn doses that they don't need - even if they start administering boosters.

Joe Biden wants more global vaccine equality but the US and other nations have not backed promises with action.

18/09/2021

Should We Use Sliding Scale Insulin Alone for Patients Hospitalized with Diabetes?

Dogma during the past decade has been that SSI is inappropriate for inpatients with diabetes.

However, a recent study suggests that many inpatients with diabetes can be managed safely and effectively with SSI alone, including most patients with admission BG of

*Corresponding Author: Guillermo E Umpierrez, MD, CDE; Email: geumpie@emory.edu; Telephone: 404-778-1665.

18/09/2021

Vaccines are one of the available options to prevent COVID-related deaths and hospitalisations.

Some deaths after vaccination are always expected because vaccines are not 100% effective.

As the number of people receiving 2 doses of vaccines increases in the UK, the number of deaths decreases to single or double digits.

13/07/2021

SARS-CoV-2 - Variants and Mutations

13/07/2021

Our findings align with the phase 3 RCT (Po**ck et al) of BNT162b2 mRNA vaccine, though with a lower protective rate; limited data on immunocompromised individuals, effectiveness against different variants of concern, longer f/ups; all stakeholders should be encouraged to report ADRs data:

This paper aims to summarize through meta-analyses the overall vaccine effectiveness of the BNT162b2 mRNA vaccine from observational studies. A systematic literature search with no language restriction was performed in electronic databases to identify eligible observational studies which reported th...

01/10/2020

ACEi/ARB use reduces the risk of mortality in COVID-19 and does not increase the risk of developing a severe form of COVID-19. The findings are based on the analysis of 60,000 COVID-19 patients from 29 studies. Read full text for details

The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was alleged to cause a more severe course of novel coronavirus disease 2019 (COVID-19). We systematically reviewed the published studies to asses...

16/05/2020

Community pharmacists are one of the most accessible healthcare professionals and are often served as the first point of contact when it comes to mino…

06/03/2018

Series: Understanding Pharmaceutical Care: Theory and Practice

Post #1: Q & A with Dr Syed Imran Ahmed (Program Director and Senior Lecturer, International Medical University)

1 I mportance of Pharmaceutical Care in 21 st Century It is very essential to provide real meaning to patient care. As we have emb...